We are pleased to be hosting this special seminar as part of the firm’s focus providing meaningful education events around the 2019 J.P. Morgan Healthcare Conference.
Arbitration is rapidly becoming the preferred dispute resolution mechanism for the life sciences sector as cross-border M&A transactions become the norm. Cross-border transactions often involve complex and lengthy processes to be finalized, especially in this sector, and such complexity paves the way for the potential of disputes at various stages in the transaction timeline.
Please join senior counsel Haig Oghigian, F.C.I. Arb., as he explores the critical aspects of the related arbitration process. In this 90-minute session, Haig will discuss how to navigate these disputes, from pre-signing to closing stages as transactions run their course. He will also address a number of important issues, including, among others, the applicable law stated in the agreement, guidance for execution of a letter of intent, interim relief, specific performance and implications based on the nature of the transaction involved.